Edesa Biotech, Inc. (EDSA)

NASDAQ: EDSA · USD

$2.28

-0.16 (-6.6%)· Recorded snapshot

Market cap	30.8M
Net income (ttm)	-14.1M
EPS (ttm)	-$1.73
Shares out	13.5M
Volume	53,260.079
Beta	1.24

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -14.1M
EPS (ttm): -$1.73
Market cap: 30.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Manter

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 14:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-122.9

P25 n/aP50 n/aP75 n/a

ROIC-79.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All EDSA indicators

Market & fundamental data

Available fields

175

Groups with data

Currency

USD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001540159
Company name	Edesa Biotech, Inc.
Country	Canada
Country code	US
CUSIP number	27966L306
Earnings date	2026-12-11
Earnings time	amc
Employees	17
Employees change	1
Employees growth	6.25%
Enterprise value	$20.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	September
Founded	2015
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	CA27966L3065
Last 10-K release date	2025-12-12
Last earnings date	2026-08-13
Last refreshed	2026-11-04
Last stock split date	2023-10-11
Last stock split type	Reverse
Market cap	$30.8M
Market cap category	Nano-Cap
Next earnings date	2026-12-11
Options	No
Price	$2.28
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-11-03
Symbol	EDSA
Website	https://www.edesabiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-75.96%
FCF / EV yield	-43.51%
FCF yield	-28.91%
P/B ratio	55.05x
Sector forward P/E	24x
Sector P/E	49.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	$-829,528
ROA	-66.43%
ROA (5Y)	-77.39%
ROCE	-166.02%
ROE	-122.93%
ROE (5Y)	-122.97%
ROIC	-79.7%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	3
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	$102,844
EBIT	$-14.6M
EBITDA	$-14.5M
EPS	$-1.73
FCF per share	$-0.66
Financing cash flow	$7M
Free cash flow	$-8.9M
Free cash flow minus SBC	$-10.7M
Income taxes	$800
Net cash flow	$-2M
Net income	$-14.1M
Operating cash flow minus SBC	$-10.7M
Operating income	$-14.6M
Stock-based compensation	$1.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$0.04
Debt / equity	0
Long-term assets	$1.9M
Long-term liabilities	$0
Net cash (debt)	$10.3M
Net cash / market cap	33.54%
Net cash growth	-16.41%
Net debt / equity	-1.17
Piotroski F-Score	1
Shareholders' equity	$8.8M
Tangible book value	$-1.5M
Tangible book value per share	$-0.16
Total assets	$12.7M
Total cash	$10.3M
Total debt	$0
Total liabilities	$3.9M
WACC	10.94%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$10.8M
Current liabilities	$3.9M
Current ratio	2.76
Net working capital	$-3.5M
Quick ratio	2.7
Working capital	$6.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-72.33%
Dividend yield	0%
Shareholder yield	-72.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$6.45
1D price change	-6.56%
1M price change	-40.93%
1M total return	-40.93%
1W price change	-13.31%
1W total return	-13.31%
1Y price change	22.58%
1Y return CAGR	22.6%
1Y total return	22.58%
20-day SMA	$2.83
200-day SMA	$5.67
3M price change	-55.38%
3M total return	-55.38%
3Y price change	-33.14%
3Y return CAGR	-12.55%
3Y total return	-33.14%
50-day SMA	$3.69
50-day SMA vs 200-day SMA	50under200
52-week high	$20.32
52-week high date	2026-05-01
52-week low	$0.72
52-week low date	2026-02-20
5Y price change	-96.23%
5Y return CAGR	-48.11%
5Y total return	-96.23%
6M price change	-87.04%
6M total return	-87.04%
After-hours change	10.53%
After-hours close	$2.28
After-hours price	$2.52
All-time high	$133.70
All-time high date	2020-07-30
All-time low	$0.72
All-time low date	2026-02-20
Average true range (ATR)	$0.28
Average volume	46.9K
Beta (1Y)	-2.05
Beta (2Y)	-0.25
Beta (5Y)	1.24
Change from 52-week high	-88.78%
Change from 52-week low	216.67%
Change from all-time high	-98.29%
Change from all-time low	216.67%
Change from open	-8.43%
Day's gap	2.05%
Dollar volume	$121,433
High price	$2.49
Low price	$2.24
Monthly RSI	44.81
Open price	$2.49
Position in 52-week range	14.63%
Premarket change	1.47%
Premarket close	$2.28
Premarket price	$2.31
Previous close	$2.44
Price vs 150-day SMA	-64.62%
Price vs 20-day SMA	-19.29%
Price vs 200-day SMA	-59.77%
Price vs 50-day SMA	-38.28%
Relative volume	1.13
RSI	27.88
Sharpe ratio	0.86
Sharpe ratio (3Y)	0.44
Sharpe ratio (5Y)	0
Sortino ratio	2.09
Sortino ratio (3Y)	1.01
Sortino ratio (5Y)	0.07
Volume	53.3K
Weekly RSI	37.6
YTD price change	60.56%
YTD total return	60.56%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10M
Float percentage	74.21%
Shares change (QoQ)	5.46%
Shares change (YoY)	72.33%
Shares held by insiders	10.46%
Shares held by institutions	27.21%
Shares outstanding	13.5M
Short % of float	1.61%
Short % of shares	1.19%
Short ratio	3.6 days

Deeper analysis on EDSA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this EDSA report

Is a complete EDSA research report available?

No complete published report is available for Edesa Biotech, Inc. (EDSA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Edesa Biotech, Inc. (EDSA)

Price

Financial snapshot

Fair-value bridge

Latest news · EDSA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EDSA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EDSA

Frequently asked questions